CRSP
#1279
CRISPR Therapeutics AG - Common Shares
57.7 2 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.78%
Variación mensual
+21.01%
Variación en los últimos 6 meses
-0.55%
Cambio anual
+13.18%
Cierres anteriores
59.3 7
Open
57.7 2
Mínimo
57.7 2
Máximo
57.7 2
Volumen
119
Financials
- Market Capitalization 5.58 B
- Employee 393
- Founded 2013
- CEO Samarth Kulkarni
- Website www.crisprtx.com
- Headquarter Switzerland
- FIGI UNKNOWN
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.11
Relación precio/flujo de caja
1 343.5
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1248 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 59.99 USD | -3.13% | -1.28% | -4.67% | +47.07% | 5.81 B USD | ||
| 1276 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 280.49 USD | -1.42% | -2.02% | -2.53% | +49.90% | 5.59 B USD | ||
| 1289 |  DFTX Definium Therapeutics, Inc. - Common Shares | 40.98 USD | -6.48% | -7.64% | -3.10% | +171.21% | 5.51 B USD | ||
| 1348 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 29.11 USD | -2.09% | -1.32% | +11.40% | +12.35% | 5.02 B USD |